Vicore Pharma Holding AB
F:6Y4
Vicore Pharma Holding AB
F:6Y4
Price:
0.96
EUR
-0.62%
Market Closed
Market Cap:
€107.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vicore Pharma Holding AB
F:6Y4
|
SE |
|
H
|
Hirogin Holdings Inc
OTC:HROGF
|
JP |
|
F
|
Felix Gold Ltd
OTC:FXGDF
|
AU |
|
J
|
Japan Airlines Co Ltd
F:JAL
|
JP |
|
C
|
China Eastern Airlines Corp Ltd
F:CIAH
|
CN |
|
Balyo SA
F:1BO
|
FR |
|
N
|
NRW Holdings Ltd
F:3NR
|
AU |
|
OSB Group PLC
F:2UK
|
UK |
Wall St Price Targets
6Y4 Price Targets Summary
Vicore Pharma Holding AB
Vicore Pharma Holding AB
Wall Street analysts forecast 6Y4 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 6Y4 is 2.57 EUR with a low forecast of 1.44 EUR and a high forecast of 3.79 EUR.
Lowest Forecast
Price Target
1.44
EUR
50% Upside
Average Forecast
Price Target
2.57
EUR
168% Upside
Highest Forecast
Price Target
3.79
EUR
295% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6Y4's stock price target?
Price Target
2.57
EUR
2.57
EUR
According to Wall Street analysts, the average 1-year price target for 6Y4 is 2.57 EUR with a low forecast of 1.44 EUR and a high forecast of 3.79 EUR.
What is the Revenue forecast for Vicore Pharma Holding AB?
Projected CAGR
139%
139%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 139%.
